InsomniaEvidence & Dosage
Acute and chronic insomnia — CBT-I as first-line therapy.
Evidence at a glance
- Total studies
- 1,000
- With abstract
- 50
- Meta / Systematic / RCT
- 5
- Highly cited
- 50
- Publication years
- 1972–2026
Insomnia in the context of Sleep
This topic is part of our "Sleep" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.
Go to SleepTop studies on Insomnia
Ranked by influential-citation count and publication year.
The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response.
Sleep2011n=959388 influential citations<h4>Background</h4>Although insomnia is a prevalent complaint with significant morbidity, it often remains unrecognized and untreated. Brief and valid instruments are needed both for screening and outcome assessment. This study examined…
Epidemiology of insomnia: what we know and what we still need to learn.
Sleep Medicine Reviews2002200 influential citationsEpidemiologists have published more than 50 studies of insomnia based on data collected in various representative community-dwelling samples or populations. These surveys provide estimates of the prevalence of insomnia according to four…
Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I.
Sleep1999n=1,000200 influential citationsThe National Sleep Foundation in conjunction with the Gallup Organization conducted telephone interviews with a sample of Americans (N = 1000) to examine the prevalence and nature of difficulty with sleep. Consistent with other national…
Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review.
Sleep1999200 influential citationsThis paper reviews the evidence regarding the efficacy of nonpharmacological treatments for primary chronic insomnia. It is based on a review of 48 clinical trials and two meta-analyses conducted by a task force appointed by the American…
Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications.
The Journal of clinical endocrinology and metabolism2001174 influential citationsAlthough insomnia is, by far, the most commonly encountered sleep disorder in medical practice, our knowledge in regard to its neurobiology and medical significance is limited. Activation of the hypothalamic-pituitary-adrenal axis leads to…
An epidemiological study of insomnia among the Japanese general population.
Sleep2000n=3,030121 influential citationsThe study examined the prevalence and correlates of insomnia in a representative sample (n=3030) from the general population of Japan. Using a structured questionnaire, we found that the overall prevalence of insomnia during the preceding…
The epidemiology of sleep and obesity.
Sleep Health2017Review115 influential citationsSleep is a state of consciousness that is preserved across animal species whose exact function is not yet clear but which has a vital impact on health and well-being. Epidemiological evidence suggests sleep duration in both children and…
Sleep disturbances and psychiatric disorders associated with posttraumatic stress disorder in the general population.
Comprehensive psychiatry2000107 influential citationsThe aim of the study was to assess sleep disturbances in subjects with posttraumatic stress disorder (PTSD) from an urban general population and to identify associated psychiatric disorders in these subjects. The study was performed with a…
European guideline for the diagnosis and treatment of insomnia.
J Sleep Res2017other104 influential citationsThis European guideline for the diagnosis and treatment of insomnia was developed by a task force of the European Sleep Research Society, with the aim of providing clinical recommendations for the management of adult patients with…
Quality of life in people with insomnia.
Sleep1999n=261104 influential citations<h4>Objective</h4>To determine whether subjects with insomnia report greater reductions in quality of life (QoL) than subjects without insomnia when assessed with self-report instruments.<h4>Methods</h4>Questionnaires were completed by…
Frequently asked
Which population does the evidence apply to?
Are there safety considerations for Insomnia?
Related articles
More topics in Sleep
Glycine
Glycine, sleep quality, body temperature and safety.
Alcohol & Sleep
Faster sleep onset, but REM suppression and night-time waking.
Antihistamines
Diphenhydramine, doxylamine — sleep fragmentation, anticholinergic dementia risks.
Apigenin
Chamomile, GABA modulation, and sleep quality.
Apigenin (Sleep)
A flavonoid from chamomile, GABA modulation, sleep quality.
Ashwagandha (Sleep)
Cortisol lowering, sleep quality — KSM-66 and Sensoril extracts.
Bedroom Darkness
Blackout curtains, sleep mask — melatonin and sleep depth.
Bedroom Temperature
Optimal 17–19°C — a falling core body temperature promotes sleep.
Benzodiazepines
Sedative/hypnotic — dependence, cognitive risks in older age.
Blue Light Filter
f.lux, Night Shift, glasses — the evidence and the marketing hype.
Bruxism
Teeth grinding — stress, night guard, trigger factors.
Caffeine Timing
Half-life ~5–6h — cut off 8–10h before sleep.
CBD for Sleep
Endocannabinoid system, REM effects, and dosage spectrum.
CBT-I
Cognitive behavioral therapy for insomnia — first-line therapy per the guidelines.
Circadian Rhythm
The internal ~24h clock — light as the main signal, peripheral clocks in the organs.
CPAP
Continuous positive airway pressure — the standard for moderate apnea.
Deep Sleep
N3 slow-wave sleep — physical recovery, GH release.
GABA Supplements
Blood-brain barrier, fermented GABA, and efficacy data.
Glycine for Sleep
Deep sleep, lowering body temperature, and 3 g in the evening.
Glycine (Sleep)
3g before bed — lowers core body temperature, modulates deep sleep.
Related topics from other worlds
Vitamin K2 (MK-7)
Calcium routing, bone health, arterial calcification and synergy with vitamin D3.
Body Temperature Tracking
Basal temperature, cycle, illness, sleep stages via wearable.
Homocysteine
Methylation marker, cardiovascular and neurological risk.
Nutrition Tracking
Cronometer, MyFitnessPal, macros & micros, limitations.
Adrenaline & Noradrenaline
Acute stress response, sympathetic nervous system, attention and reaction.
DHT
The most potent androgen metabolite — hair loss, prostate, libido.